Brenzavvy Alternatives Compared
Brenzavvy (bexagliflozin) | Rybelsus (semaglutide) | Mounjaro (tirzepatide) |
|
---|
Brenzavvy (bexagliflozin) | Rybelsus (semaglutide) | Mounjaro (tirzepatide) |
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Type 2 Diabetes. Brenzavvy may also be used for purposes not listed in this medication guide. |
Prescription only
Rybelsus (semaglutide) is an oral medicine that can be used as a first-line medication to improve blood sugar control in adults over the age of 18 with type 2 diabetes. It works by mimicking the... View more |
Prescription only
Prescribed for Weight Loss (Obesity/Overweight), Type 2 Diabetes. Mounjaro may also be used for purposes not listed in this medication guide. |
Related suggestions Type 2 Diabetes
|
|||||||||||||||||||||||
More about Brenzavvy (bexagliflozin) | More about Rybelsus (semaglutide) | More about Mounjaro (tirzepatide) | ||||||||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||||||||||
Brenzavvy has an average rating of 10.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Rybelsus has an average rating of 6.4 out of 10 from a total of 266 ratings on Drugs.com. 48% of reviewers reported a positive effect, while 25% reported a negative effect. |
Mounjaro has an average rating of 8.6 out of 10 from a total of 1137 ratings on Drugs.com. 80% of reviewers reported a positive effect, while 6% reported a negative effect. |
||||||||||||||||||||||||
Drug Class | ||||||||||||||||||||||||||
Side Effects | ||||||||||||||||||||||||||
Generic Availability | ||||||||||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Brenzavvy prices |
View all Rybelsus prices |
View all Mounjaro prices |
||||||||||||||||||||||||
Dosage Forms Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names | ||||||||||||||||||||||||||
N/A |
Other semaglutide brands include: Ozempic, Wegovy | Other tirzepatide brands include: Zepbound | ||||||||||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
12 hours |
168 hours |
120 hours |
||||||||||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category | ||||||||||||||||||||||||||
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||||||||||
Drug Interactions | ||||||||||||||||||||||||||
A total of 365 drugs are known to interact with Brenzavvy:
|
A total of 267 drugs are known to interact with Rybelsus:
|
A total of 412 drugs are known to interact with Mounjaro:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
Disease Interactions | ||||||||||||||||||||||||||
First Approval Date | ||||||||||||||||||||||||||
January 20, 2023 |
September 20, 2019 |
N/A |
||||||||||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||||||||||
More Information | ||||||||||||||||||||||||||
Patient resources | ||||||||||||||||||||||||||
Professional Resources | ||||||||||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.